Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 20...

Alcon Inc. Ordinary Shares (ALC) has a valuation score of 60/100 (moderate), profitability score of 50/100 (moderate), financial health score of 80/100 (strong), Piotroski F-Score of 3/9, Altman Z-Score of 3.83 (safe zone), revenue growth of +6.1% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations20 analysts · 2026-08-01
4
12
2
2
Strong Buy 4Buy 12Hold 2Sell 2Strong Sell 0

Recent Market Moves

See all ALC moves →
DateSessionPriceMoveZ-Score
Aug 12Pre-market$72.55-3.72%-2.48
Aug 11Pre-market$76.34+3.68%2.45
Aug 7Regular$71.73+3.15%2.10
Aug 7After-hours$71.81+3.26%2.18
Alcon Inc. Ordinary Shares (ALC) Valuation & P/E History →Alcon Inc. Ordinary Shares (ALC) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →